Harmonia MentisHarmonia Mentis

ONTOZRY®▼ (cenobamate): International Insights and Expertise
Roadshow 2023

  1. Home
  2. UK HCP
  3. ONTOZRY®▼ (cenobamate)
    On Demand

  4. You are here: ONTOZRY®▼ (cenobamate): International Insights and Expertise Roadshow 2023

Article

This webpage is intended for UK-I healthcare professionals.

▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Adverse events and product complaint should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard for the UK or www.hpra.ie for Ireland. Adverse events and product complaint should also be reported to Angelini Pharma on (UK) +44 2034889643, (IRE) +353 1 584 4671 or UKIReporting@angelinipharma.com

ⓘ Click here for Prescribing Information and Adverse Event Reporting

ONTOZRY®: International Insights and Expertise. Roadshow 2023

We recently invited global experts Professor Gergory Krauss and Professor Bernhard Steinhoff to the UK-I to share their experience with ONTOZRY®. They shared recent audit data from their clinics along with case studies on particularly challenging patients. Local experts also shared local audit data and case studies from their clinic.

UK22977P | April 2024

UK23589P | June 2024

;